Inventor
KLEIN J PETER
US50 patents
⚠️ This page may combine multiple inventors who share the name “KLEIN J PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELL THERAPEUTICS INC
49 patentsUS5780476AJul 14, 1998
Hydroxyl-containing xanthine compounds
CELL THERAPEUTICS INC95 citations98
US5807861ASep 15, 1998
Amine substituted xanthinyl compounds
CELL THERAPEUTICS INC106 citations97
US5804584ASep 8, 1998
Therapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atoms
CELL THERAPEUTICS INC39 citations96
US5641783AJun 24, 1997
Substituted amino alcohol compounds
CELL THERAPEUTICS INC57 citations96
US5470878ANov 28, 1995
Cell signaling inhibitors
CELL THERAPEUTICS INC74 citations96
US5817662AOct 6, 1998
Substituted amino alkyl compounds
CELL THERAPEUTICS INC47 citations95
US5807862ASep 15, 1998
Therapeutic compounds containing pyrimidinyl moieties
CELL THERAPEUTICS INC53 citations95
US5340813AAug 23, 1994
Substituted aminoalkyl xanthine compounds
CELL THERAPEUTICS INC52 citations95
US7208507B2Apr 24, 2007
Pyridines and uses thereof
CELL THERAPEUTICS INC22 citations93
US6875781B2Apr 5, 2005
Pyridines and uses thereof
CELL THERAPEUTICS INC34 citations93
US7618968B2Nov 17, 2009
Aryl triazines as LPAAT-β inhibitors and uses thereof
CELL THERAPEUTICS INC24 citations92
US7291616B2Nov 6, 2007
Aryl triazines as LPAAT-β inhibitors and uses thereof
CELL THERAPEUTICS INC26 citations92
US6878715B1Apr 12, 2005
Therapeutic compounds for inhibiting interleukin-12 signals and method for using same
CELL THERAPEUTICS INC46 citations92
US6774130B2Aug 10, 2004
Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
CELL THERAPEUTICS INC22 citations92
US6469017B1Oct 22, 2002
Method of inhibiting interleukin-12 signaling
CELL THERAPEUTICS INC17 citations92
US6133274AOct 17, 2000
Hydroxyl-containing bicyclic compounds
CELL THERAPEUTICS INC26 citations92
US6020337AFeb 1, 2000
Electronegative-substituted long chain xanthine compounds
CELL THERAPEUTICS INC36 citations92
US5837703ANov 17, 1998
Amino-alcohol substituted cyclic compounds
CELL THERAPEUTICS INC33 citations92
US5801181ASep 1, 1998
Amino alcohol substituted cyclic compounds
CELL THERAPEUTICS INC38 citations92
US5770595AJun 23, 1998
Oxime substituted therapeutic compounds
CELL THERAPEUTICS INC40 citations92
US5629423AMay 13, 1997
Asymmetric synthesis of chiral secondary alcohols
CELL THERAPEUTICS INC21 citations92
US5288721AFeb 22, 1994
Substituted epoxyalkyl xanthines
CELL THERAPEUTICS INC31 citations92
US5801182ASep 1, 1998
Amine substituted compounds
CELL THERAPEUTICS INC50 citations91
US7419984B2Sep 2, 2008
Pyrimidines and uses thereof
CELL THERAPEUTICS INC26 citations90
US5756511AMay 26, 1998
Method for treating symptoms of a neurodegenerative condition
CELL THERAPEUTICS INC19 citations84
US5777117AJul 7, 1998
Method for preparing substituted amino alcohol compounds
CELL THERAPEUTICS INC15 citations82
US5866576AFeb 2, 1999
Epoxide-containing compounds
CELL THERAPEUTICS INC15 citations81
US6075029AJun 13, 2000
Xanthine modulators of metabolism of cellular P-450
CELL THERAPEUTICS INC12 citations74
US5750575AMay 12, 1998
Substituted amino alcohol compounds
CELL THERAPEUTICS INC4 citations74
US6693105B1Feb 17, 2004
Hydroxyl-containing compounds
CELL THERAPEUTICS INC11 citations73
US6586429B2Jul 1, 2003
Tricyclic fused xanthine compounds and their uses
CELL THERAPEUTICS INC6 citations73
US6100271AAug 8, 2000
Therapeutic compounds containing xanthinyl
CELL THERAPEUTICS INC12 citations73
US6043250AMar 28, 2000
Methods for using therapeutic compounds containing xanthinyl
CELL THERAPEUTICS INC12 citations73
US5889011AMar 30, 1999
Substituted amino alkyl compounds
CELL THERAPEUTICS INC14 citations73
US5473070ADec 5, 1995
Substituted long chain alcohol xanthine compounds
CELL THERAPEUTICS INC18 citations73
US5354756AOct 11, 1994
Olefin-substituted long chain xanthine compounds
CELL THERAPEUTICS INC12 citations73
US6103730AAug 15, 2000
Amine substituted compounds
CELL THERAPEUTICS INC13 citations72
US7153864B2Dec 26, 2006
Polyglutamic acid-camptothecin conjugates and methods of preparation
CELL THERAPEUTICS INC10 citations71
US6780865B1Aug 24, 2004
Compounds having selective hydrolytic potentials
CELL THERAPEUTICS INC12 citations71
US5824677AOct 20, 1998
Substituted amino alcohol compounds
CELL THERAPEUTICS INC1 citations63
US6121270ASep 19, 2000
Epoxide-containing compounds
CELL THERAPEUTICS INC3 citations62
US5521315AMay 28, 1996
Olefin substituted long chain compounds
CELL THERAPEUTICS INC5 citations61
US7608620B2Oct 27, 2009
LPAAT-β inhibitors and uses thereof
CELL THERAPEUTICS INC1 citations58
US7399860B2Jul 15, 2008
Manufacture of polyglutamate-therapeutic agent conjugates
CELL THERAPEUTICS INC4 citations58
US7064125B2Jun 20, 2006
LPAAT-β inhibitors and uses thereof
CELL THERAPEUTICS INC2 citations58
US7247630B2Jul 24, 2007
Uses of tricyclic compounds
CELL THERAPEUTICS INC0 citations51
US7173041B2Feb 6, 2007
Polyglutamic acid-camptothecin conjugates and methods of preparation
CELL THERAPEUTICS INC0 citations50
US7053096B2May 30, 2006
Compounds having selective hydrolytic potentials
CELL THERAPEUTICS INC1 citations50
US6825180B2Nov 30, 2004
Pyridopyrimidine compounds and their uses
CELL THERAPEUTICS INC1 citations47